Skip to Content

Bromfenac Ophthalmic Dosage

Applies to the following strength(s): 0.09% ; 0.07%

The information at is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.

Usual Adult Dose for:

Additional dosage information:

Usual Adult Dose for Postoperative Ocular Inflammation

For the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery:
Bromday (bromfenac ophthalmic solution 0.09%) and Prolensa (bromfenac ophthalmic solution 0.07%) :
- one drop applied to the affected eye(s) once daily beginning 1 day prior to cataract surgery, continued on the day of surgery, and through the first 14 days of the postoperative period.

Bromfenac ophthalmic, like most topical nonsteroidal anti-inflammatory agents may increase the risk for the occurrence and severity of corneal adverse events if instilled more than 24 hours prior to and longer than 2 weeks following cataract surgery.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available


Safety and efficacy have not been established in pediatric patients less than 18 years old.


Data not available

Other Comments

Administration advice:
-Bromfenac ophthalmic solution should not be administered while wearing contact lenses. Remove contacts prior to instilling Prolensa and reinsert 10 minutes following administration. Contact lenses should not be worn during the use of Bromday.
-Avoid allowing the tip of the container to contact the eye, eyelid, fingers or any other surface to avoid contamination.
-If using more than one ophthalmic medication, administer them at least 5 minutes apart.

Patient advice: A single bottle of Prolensa should be used to treat only one eye.